The analgesic effect of Captor Simplex may be weakened and/or shortened if you are taking other medications that contain:
Your doctor will indicate if you should take Captor Simplex and at what dose.
The risk of adverse effects increases,
Do not take Captor Simplex at the same time as the medications called "monoamine oxidase inhibitors" (used to treat depression) or if you have taken any in the past two weeks.
The concomitant use of Captor Simplex with sedatives such as benzodiazepines or medications that increase the risk of drowsiness, respiratory depression, coma, and may be potentially fatal. Therefore, it should only be considered when other treatment options are not possible.
However, if your doctor prescribes Captor Simplex with sedatives, you should limit the dose and duration of concomitant treatment.
Inform your doctor about all sedatives you are taking and strictly follow your doctor's recommended dose. It may be helpful to inform your friends and family about the signs and symptoms mentioned above. Inform your doctor if you experience any of these symptoms.
Taking Captor Simplex with food and alcohol
Do not consume alcohol during treatment with Captor Simplex, as its effect may be intensified. Food does not affect the effect of Captor Simplex.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medication.
Captor Simplex may affect the fetus. Therefore, it should not be taken during pregnancy.
Tramadol is excreted in breast milk. Therefore, do not take Captor Simplex more than once during breastfeeding, or if you take Captor Simplex more than once, you should stop breastfeeding.
Based on human experience, it is not suggested that tramadol affects male and female fertility.
Driving and using machines
Ask your doctor if you can drive or use machines during treatment with Captor Simplex. It is essential to observe how this medication affects you before driving or using machines. Do not drive or use machines if you feel drowsy, dizzy, have blurred vision, or double vision, or have difficulty concentrating. Be especially careful at the beginning of treatment, when changing to another treatment, and when administering it concomitantly with other medications.
Captor Simplex contains saccharose and benzoic acid
This medication contains saccharose. If your doctor has indicated that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 0.015 mg of benzoic acid per unit dose.
The dose should be adjusted to the intensity of the pain and individual sensitivity. Normally, the smallest dose possible that produces pain relief should be used.
Follow exactly the administration instructions for Captor simplex indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during it, your doctor will also explain what you can expect from the use of CAPTOR SIMPLEX, when and for how long you should use it, when you should contact your doctor, and when you should discontinue use (see also section 2).
Below are the usual doses.The dose may be increased or decreased gradually by your doctor depending on your response to treatment.
Adults and adolescents 12 years or older:
The usual dose is one to two 100 mg capsules taken twice a day, which is equivalent to 200 to 400 mg per day. The capsules should be taken in the morning and at night. Normally, do not take more than 400 mg per day.
Use in children:
The use of this medication is not suitable for children with a weight of less than 25 kg, which generally means that it should not be administered to children under 12 years old. Other forms of this medication may be more suitable for use in children; ask your doctor, pharmacist, or nurse.
Elderly patients:
In elderly patients (over 75 years), the elimination of tramadol may be slow. If this is your case, your doctor may recommend prolonging the dosing intervals.
Patients with liver or kidney disease/patients on dialysisIf you have any severe liver or kidney disease, treatment with Captor simplex is not recommended. If you have moderate liver or kidney disease, your doctor may prolong the dosing intervals.
Administration form:
This medication is taken orally.
The capsules should be swallowed whole, with a glass of water.
The capsules can be taken with or without food. Do not crush, divide, or break them.
For how long should you take Captor simplex?
This medication should not be administered for longer than strictly necessary.
If prolonged treatment is required, your doctor will monitor you at short and regular intervals (if necessary, with interruptions in treatment) to determine if you should continue treatment with this medication and at what dose.
If you estimate that the effect of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Captor simplex than you should
If you have taken Captor simplex more than you should, consult your doctor or pharmacist immediately or the Toxicological Information Service, phone 915 620 420.You may experience various symptoms, including: pupil constriction, vomiting (dizziness), decreased blood pressure, tachycardia, lipotimia, fainting, or even coma, seizures, and respiratory difficulties or shallow breathing.
.
If you forgot to take Captor simplex, take it as soon as you remember and then continue taking it as before.Do not take a double dose to compensate for a missed dose.
If you interrupt treatment with Captor simplex, the pain may return.
.
Do not stop taking this medication suddenly, consult your doctor first, especially if you have been taking it for a long time. Your doctor will inform you when and how to discontinue it, which can be done by gradually reducing the dose to reduce the likelihood of unnecessary adverse effects (withdrawal symptoms).
If you have been taking this medication for a very long time and discontinue treatment suddenly, you may experience the following adverse effects: restlessness, anxiety, nervousness, tremors, or stomach pain.Very few people may experience panic attacks, hallucinations, unusual perceptions such as itching, numbness, and tingling, and "buzzing" in the ears (tinnitus). Very rarely, other unusual central nervous system symptoms have been seen, such as confusion, delirium, distorted perception of one's own personality (derealization), and altered perception of reality (despersonalization) and delusional persecution (paranoia).If you experience any of these effects after discontinuing treatment with Captor simplex, consult your doctor.
If you have any other questions about the use of thismedication, ask your doctor, pharmacistor nurse.
Like all medicines, Captor simplex may cause side effects, although not everyone will experience them.
Captor simplex may occasionally cause allergic reactions, although severe allergic reactions (including anaphylaxis and angioedema) are rare.Inform your doctor immediately if you experience sudden wheezing or shortness of breath, difficulty breathing, swelling of the eyelids, face, or lips, skin rash or itching (especially if it affects your entire body).
The following side effects may occur:
Very common: may affect more than 1 in 10 patients
|
|
Common: may affect up to 1 in 10 patients
|
|
Uncommon: may affect up to 1 in 100 patients
|
|
Rare: may affect up to 1 in 1,000 patients
|
|
Very rare: may affect fewer than 1 in 10,000 patients)
|
Frequency not known (cannot be estimated from available data):
When treatment is suddenly discontinued, signs of drug withdrawal syndrome may appear (see "If you stop taking Captor simplex").
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse,even if it is a possible side effect that does not appear in this leaflet.You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano (www.notificaRAM.es).By reporting side effects, you can contribute to providing more information on the safety of this medicine
Keep this medication out of the sight and reach of children.
Conserve this medication in a safe and protected place, to which other people cannot access. This medication can cause serious harm or even be fatal to individuals who have not been prescribed it.
Do not use this medication after the expiration date that appears on the blister pack and the box. The expiration date is the last day of the month indicated.
Do not store at temperatures above 25°C
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Captor Simplex Composition
Sugar spheres (cornstarch and sucrose)
Macrogol 4000
30% polyacrylate dispersion (ethyl acrylate, methyl methacrylate, nonoxinol)
Simethicone emulsion (simethicone, triestearate of polyoxyethylene-sorbitan, methylcellulose, polyethylene glycol stearate, glycerides, xanthan gum, benzoic acid, sorbic acid, sulfuric acid)
Hypromellose
Talc
Gelatin
Titanium dioxide (E 171)
Yellow iron oxide (E172)
Product appearance and packaging contents
Yellow opaque head and transparent body gelatin capsules containing white spherical microgranules (“microspheres”).
Boxes containing 20 and 60 prolonged-release hard capsules (prolonged-release capsules).
Marketing authorization holder:
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 Barcelona
Responsible for manufacturing:
Ferrer Internacional, S.A.
Joan Buscallá, 1-9
08173 – Sant Cugat del Vallés (Barcelona)
Or
Ethypharm
Chemin de la Poudrière
F-76120 Grand-Quevilly (France)
Or
Toll Manufacturing Services, S.L.
Aragoneses, 2
28108 Alcobendas (Spain)
Or
Macarthys Laboratories Limited
Bampton road, Harold hill,
Romford, RM38UG
United Kingdom
This medicine is authorized in the Member States of the European Economic Area with the following names:
Germany | Tramadol Ethypharm |
Ireland | By-Madol SR |
Portugal | Gelotralib |
United Kingdom | Maxitram SR |
Last review date of this leaflet: July 2024
For detailed and updated information on this medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.